CN101550137A - Method for synthesizing famciclovir - Google Patents
Method for synthesizing famciclovir Download PDFInfo
- Publication number
- CN101550137A CN101550137A CNA2009103022016A CN200910302201A CN101550137A CN 101550137 A CN101550137 A CN 101550137A CN A2009103022016 A CNA2009103022016 A CN A2009103022016A CN 200910302201 A CN200910302201 A CN 200910302201A CN 101550137 A CN101550137 A CN 101550137A
- Authority
- CN
- China
- Prior art keywords
- diethyl malonate
- chloropurine
- acetic ester
- methyl
- mol ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to a method for synthesizing famciclovir, which includes preparing sodium salt of diethyl malonate at the acting of sodium ethylate by taking diethyl malonate as raw charge and ethyl hydrate as dissolvent, preparing bromo ethyl group diethyl malonate by carrying out nucleophilic substitution reaction with 1, 2-dibromoethane and sodium salt of diethyl malonate, preparing bromo ethyl group propanediol by deoxidizing bromo ethyl group diethyl malonate at the acting of sodium borohydride, preparing 2-acetyl oxygen radicel methyl radicel -4-bromo butyl acetic ester by carrying out reaction with bromo ethyl group propanediol and acylating agent acetic oxide, preparing 2-(2-acetyl oxygen radicel-4-bromo butyl acetic ester)-6-chloropurine by carrying out condensation with 2-acetyl oxygen radicel methyl radical-4-bromo butyl acetic ester and 2-amidocyanogen-6-chloropurine, and then preparing famciclovir by carrying out dechlorination with 2-(2-acetyl oxygen radicel methyl radical -4-bromo butyl acetic ester)-6-chloropurine. This method is suitable for the industrial production with short production line, high yield and low cost.
Description
Technical field
The present invention relates to a kind of synthetic method of antiviral famciclovir.
Background technology
Famciclovir (Famciclovir) is mainly used in treatment zoster, primary genitalia herpes.DNA has restraining effect to duck hepatitis B virus.Synthetic route report about famciclovir mainly contains following 3 at present:
1,2-amino-6-chloropurine and 3-N-PROPYLE BROMIDE-1,1, the condensation of 1-tricarboxylic acid triethyl generates 2-amino-6-chloro-9-(2,2-diethoxy carbonyl ethyl butyrate-4-yl) purine is again through decarboxylation, reduction and esterification preparation method VCV, 3-N-PROPYLE BROMIDE 1,1 in this route, 1-tricarboxylic acid triethyl need self-control, reaction scheme is longer relatively, and cost is higher.
2, with 2,5-diamino 4,6-dihydroxy-pyrimidine and N-alkyl chlorimide are feedstock production, and it is that raw material is more expensive that there is shortcoming in this route, and yield is lower.
3, with 1,3-diacetoxy acetone and ethene magnesium bromide are that feedstock production goes out side chain, go out famciclovir with the amino 6-chloropurine prepared in reaction of 2-again, and this route reaction step is less relatively, but reaction needs to carry out unsuitable suitability for industrialized production under low temperature-78 ℃ condition.
Summary of the invention
The purpose of this invention is to provide a kind of can overcome above-mentioned technological deficiency that existing production technique exists, can improve convergency, take into account the method for the preparation method VCV of efficient and safety standards.
The technical scheme of adopt liking is so for achieving the above object, i.e. a kind of synthetic method of famciclovir, and it is characterized in that: method may further comprise the steps:
Step (1), in reaction flask, drop into ethanol and diethyl malonate, be warming up to 30-100 ℃, add the sodium ethylate with diethyl malonate mol ratio 2.5-1.2, in 40-85 ℃ of reaction, progressively be warming up to backflow, steam ethanol, the sodium salt of diethyl malonate;
Step (2), in reaction flask, add the ethyl acetate with diethyl malonate sodium salt mol ratio 5-30, suitable water, drop into the sodium salt of diethyl malonate, be cooled to below 10 ℃, the glycol dibromide of adding and diethyl malonate sodium salt mol ratio 0.8-5, controlled temperature is no more than 20 ℃, reaction finishes. and anhydrous magnesium sulfate drying gets the bromotrifluoromethane diethyl malonate;
Add in step (3) reaction flask bromotrifluoromethane diethyl malonate and with the DMF of bromotrifluoromethane diethyl malonate mol ratio 10-150, make homogeneous solution, be warming up to 30-80 ℃, drip sodium borohydride with bromotrifluoromethane diethyl malonate mol ratio 0.5-20, keep 40-85 ℃ of temperature, react 2-8 hour dichloromethane extraction, evaporated under reduced pressure gets the bromotrifluoromethane propylene glycol;
Step (4), backflow is housed, in the reaction flask of whipping appts, add the bromotrifluoromethane propylene glycol and with the diacetyl oxide of bromotrifluoromethane propylene glycol mol ratio 0.5-10, be heated to 80-100 ℃, continue to be warming up to back flow reaction, add washing, until pH value 5-8, get 2-acetoxy-methyl-4-brombutyl acetic ester;
Step (5), in reaction flask, drop into 2-amino-6-chloropurine, with 2-acetoxy-methyl-4-brombutyl acetic ester of 2-amino-6-chloropurine mol ratio 0.5-5, with the DMF salt of wormwood of 2-amino-6-chloropurine mol ratio 0.8-20, heat 40-95 ℃ of reaction, filter, use re-crystallizing in ethyl acetate again. obtain 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine;
Step (6) is in reaction flask, add 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine, with ethyl acetate, triethylamine and 2-(the palladium carbon of 2-acetoxy-methyl-4-brombutyl acetic ester weight 0.05-5% of 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine mol ratio 0.1-10, feed hydrogen reaction to finishing. the reduction vaporization ethyl acetate, use ethyl acetate-methyl alcohol (1: 0.1-1 again, / V) mixed solvent recrystallization, the famciclovir finished product.
The present invention is with respect to present existing synthetic technology, and have following characteristics: reactions steps is less, and starting material are cheap and easy to get, and are simple to operate, process stabilizing, and stable and reliable product quality, cost is low, has very strong
Competitive power, help suitability for industrialized production.
Embodiment
1, the making of the sodium salt of diethyl malonate
In reaction flask, drop into ethanol 400ml and 162 gram diethyl malonates, stir, be warming up to 45 degree, add 70 gram sodium ethylates in batches, in 50 ~ 55 degree reactions 3 hours, progressively be warming up to backflow, under the reflux state, reacted again 1 hour, steam about 200ml ethanol, be cooled to room temperature, begin to occur white crystals, placement is spent the night. suction filtration, with a small amount of ether washing leaching cake, drying, get the sodium salt of diethyl malonate, the white crystals thing.
2, the making of bromotrifluoromethane diethyl malonate
In the reaction flask, add ethyl acetate 350ml, water 200ml, under the vigorous stirring, drop into sodium salt 185 grams of diethyl malonate in batches, make suspension liquid, be cooled to below 10 degree, dropwise add 1,2-ethylene dibromide 188 grams, controlled temperature is no more than 20 degree, continues reaction 3 hours, limpid to solution, reaction finishes. and stop to stir, reaction solution is changed in the separating funnel over to static layering, get rid of water. use 750ml water, divide three washings, anhydrous magnesium sulfate drying, evaporate to dryness, get the bromotrifluoromethane diethyl malonate, light yellow oil.
3, the making of bromotrifluoromethane propylene glycol
In the reaction flask, add DMF250ml, bromotrifluoromethane diethyl malonate 270 grams stir, make homogeneous solution, be warming up to 50 degree, stop heating, drip the solution of making by 45 gram sodium borohydrides and 150mlDMF, the control rate of addition keeps temperature to be no more than 65 degree, reacts 5 hours, be cooled to below 30 degree, add methylene dichloride 300ml, stir, change in the separating funnel 250ml washing three times, anhydrous magnesium sulfate drying methylene dichloride phase over to, evaporated under reduced pressure gets the bromotrifluoromethane propylene glycol, light yellow liquid.
4, the making of 2-acetoxy-methyl-4-brombutyl acetic ester
Backflow is being housed, in the reaction flask of whipping appts, is adding bromotrifluoromethane propylene glycol 185 grams, 200 gram acetate
Acid anhydride, the 15ml vitriol oil is heated to 80 degree, constant temperature 2 hours continues to be warming up to backflow, reacts 8 hours, naturally cool to room temperature, be transferred in the separating funnel, add 500ml water, washing is told spent acid, repeated multiple times, until pH value greater than 6. anhydrous magnesium sulfate dryings, filter, get 2-acetoxy-methyl-4-brombutyl acetic ester, light yellow liquid.
5, the making of 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine
In reaction flask, drop into 170 gram 2-amino-6-chloropurines, 260 gram 2-acetoxy-methyl-4-brombutyl acetic ester, 550mlDMF, 25 gram salt of wormwood, heated and stirred was in 60 ~ 65 degree reactions 18 hours. and reaction finishes, be cooled to room temperature, filter, filter cake is again with a spot of DMF washing, merging filtrate. anhydrous sodium sulfate drying, to filter. underpressure distillation is to doing. use re-crystallizing in ethyl acetate again. obtain 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine, the white crystals body.
6, the making of famciclovir
In reaction flask, add 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine 200 grams, 500ml ethyl acetate, 10 gram triethylamines, 10% palladium carbon, 20 grams, stir, feed nitrogen replacement 3 times, be warming up to 60 degree again, fed hydrogen reaction 8 hours, reaction finishes. filtered and recycled palladium carbon, and with amount of ethyl acetate washing palladium carbon. merging filtrate, wash with 300ml, anhydrous magnesium sulfate drying, filter. the reduction vaporization ethyl acetate is to doing, use again ethyl acetate-methyl alcohol (85: 15, V/V) mixed solvent recrystallization, separate, drying under reduced pressure gets the famciclovir finished product, white crystals.
Technological process total recovery 61% of the present invention, used starting material are the conventional chemical raw material, production process easy handling, environmental friendliness.Product content 99.5%, other quality index reach the national drug quality standard.
Claims (1)
1, a kind of synthetic method of famciclovir is characterized in that method comprises the following steps:
Step (1), in reaction flask, drop into ethanol and diethyl malonate, be warming up to 30-100 ℃, add the sodium ethylate with diethyl malonate mol ratio 2.5-1.2, in 40-85 ℃ of reaction, progressively be warming up to backflow, steam ethanol, the sodium salt of diethyl malonate;
Step (2), in reaction flask, add the ethyl acetate with diethyl malonate sodium salt mol ratio 5-30, suitable water, drop into the sodium salt of diethyl malonate, be cooled to below 10 ℃, the glycol dibromide of adding and diethyl malonate sodium salt mol ratio 0.8-5, controlled temperature is no more than 20 ℃, reaction finishes. and anhydrous magnesium sulfate drying gets the bromotrifluoromethane diethyl malonate;
Add in step (3) reaction flask bromotrifluoromethane diethyl malonate and with the DMF of bromotrifluoromethane diethyl malonate mol ratio 10-150, make homogeneous solution, be warming up to 30-80 ℃, drip sodium borohydride with bromotrifluoromethane diethyl malonate mol ratio 0.5-20, keep 40-85 ℃ of temperature, react 2-8 hour dichloromethane extraction, evaporated under reduced pressure gets the bromotrifluoromethane propylene glycol;
Step (4), backflow is housed, in the reaction flask of whipping appts, add the bromotrifluoromethane propylene glycol and with the diacetyl oxide of bromotrifluoromethane propylene glycol mol ratio 0.5-10, be heated to 80-100 ℃, continue to be warming up to back flow reaction, add washing, until pH value 5-8, get 2-acetoxy-methyl-4-brombutyl acetic ester;
Step (5), in reaction flask, drop into 2-amino-6-chloropurine, with 2-acetoxy-methyl-4-brombutyl acetic ester of 2-amino-6-chloropurine mol ratio 0.5-5, with the DMF salt of wormwood of 2-amino-6-chloropurine mol ratio 0.8-20, heat 40-95 ℃ of reaction, filter, use re-crystallizing in ethyl acetate again. obtain 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine;
Step (6) is in reaction flask, add 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine, with ethyl acetate, triethylamine and 2-(the palladium carbon of 2-acetoxy-methyl-4-brombutyl acetic ester weight 0.05-5% of 2-(2-acetoxy-methyl-4-brombutyl acetic ester)-6-chloropurine mol ratio 0.1-10, feed hydrogen reaction to finishing. the reduction vaporization ethyl acetate, use ethyl acetate-methyl alcohol (1: 0.1-1 again, / V) mixed solvent recrystallization, the famciclovir finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2009103022016A CN101550137A (en) | 2009-05-11 | 2009-05-11 | Method for synthesizing famciclovir |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2009103022016A CN101550137A (en) | 2009-05-11 | 2009-05-11 | Method for synthesizing famciclovir |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101550137A true CN101550137A (en) | 2009-10-07 |
Family
ID=41154654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2009103022016A Pending CN101550137A (en) | 2009-05-11 | 2009-05-11 | Method for synthesizing famciclovir |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101550137A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103819338A (en) * | 2014-03-11 | 2014-05-28 | 大连来克精化有限公司 | Preparation method for alpha-methyl-diglycollic acid-diethyl ester |
CN107488176A (en) * | 2016-06-12 | 2017-12-19 | 浙江医药股份有限公司新昌制药厂 | A kind of FCV impurity C synthetic method |
CN108484605A (en) * | 2018-03-16 | 2018-09-04 | 上药康丽(常州)药业有限公司 | A kind of chloro- 9- of 2- amino -6-(4- acetoxy-3s-acetyl-o-methyl butyl)The preparation method of purine |
CN109456329A (en) * | 2018-11-19 | 2019-03-12 | 威海迪素制药有限公司 | A kind of preparation method of famciclovir |
-
2009
- 2009-05-11 CN CNA2009103022016A patent/CN101550137A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103819338A (en) * | 2014-03-11 | 2014-05-28 | 大连来克精化有限公司 | Preparation method for alpha-methyl-diglycollic acid-diethyl ester |
CN107488176A (en) * | 2016-06-12 | 2017-12-19 | 浙江医药股份有限公司新昌制药厂 | A kind of FCV impurity C synthetic method |
CN107488176B (en) * | 2016-06-12 | 2020-07-21 | 浙江医药股份有限公司新昌制药厂 | Method for synthesizing famciclovir impurity C |
CN108484605A (en) * | 2018-03-16 | 2018-09-04 | 上药康丽(常州)药业有限公司 | A kind of chloro- 9- of 2- amino -6-(4- acetoxy-3s-acetyl-o-methyl butyl)The preparation method of purine |
CN109456329A (en) * | 2018-11-19 | 2019-03-12 | 威海迪素制药有限公司 | A kind of preparation method of famciclovir |
CN109456329B (en) * | 2018-11-19 | 2021-03-09 | 迪嘉药业集团有限公司 | Preparation method of famciclovir |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108017583B (en) | Preparation method of kebomei | |
CN102584893B (en) | Preparation method for glufosinate | |
JP2020158516A (en) | Process of making cenicriviroc and related analogs | |
CN102702199A (en) | Method for preparing ganciclovir | |
CN101550137A (en) | Method for synthesizing famciclovir | |
CN101891649A (en) | Novel 3-cyano methyl benzoate preparing method | |
CN103819450B (en) | A kind of new preparation process of SYR-322 | |
CN102816123A (en) | Preparation method for cytosine | |
CN105153149B (en) | A kind of selective kinase inhibitors Palbociclib preparation method | |
CN102887885B (en) | Preparation method of esomeprazole sodium | |
CN105481694A (en) | Synthetic method of 4-methoxyethyl acetoacetate | |
CN103709164B (en) | A kind of synthetic method of adenine | |
CN101337890A (en) | Method for preparing methyl acetoacetate by using novel composite catalyst | |
CN103483324A (en) | New preparation method of lapatinib | |
CN105541801B (en) | The synthetic method of EZH2 methyltransferase inhibitors GSK126 | |
CN106187857A (en) | A kind of method preparing Apremilast | |
WO2010023679A2 (en) | Preparation of triclopyr, its intermediate and butoxyethyl ester | |
CN105622538A (en) | One-pot high-yielding preparation of cetilistat | |
CN115141180B (en) | Preparation method of ruxotinib intermediate | |
CN106187787A (en) | A kind of preparation method of 2 amino 4 chlorodiphenyl ethers | |
CN101928277B (en) | Preparation method of 4-methyl-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzoic acid, related intermediate and application thereof | |
CN116496223A (en) | Preparation method of 5-bromo-4-methyl-2-trifluoromethyl pyrimidine | |
CN109988108B (en) | Preparation method of cabozantinib | |
CN103058936B (en) | The preparation method of 4-[(the chloro-2-pyrimidyl of 4-) is amino] cyanophenyl | |
CN103755706B (en) | A kind of environment-friendly preparation method synthesizing folic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20091007 |